Masanori Iwata

567 total citations
45 papers, 467 citations indexed

About

Masanori Iwata is a scholar working on Pharmacology, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, Masanori Iwata has authored 45 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Pharmaceutical Science and 6 papers in Organic Chemistry. Recurrent topics in Masanori Iwata's work include Pharmacy and Medical Practices (9 papers), Drug Solubulity and Delivery Systems (6 papers) and Organophosphorus compounds synthesis (5 papers). Masanori Iwata is often cited by papers focused on Pharmacy and Medical Practices (9 papers), Drug Solubulity and Delivery Systems (6 papers) and Organophosphorus compounds synthesis (5 papers). Masanori Iwata collaborates with scholars based in Japan, United States and Taiwan. Masanori Iwata's co-authors include Yoshiharu Machida, Takahiro Seki, Yukikazu Takeoka, Shinya Yoshioka, Midori Teshima, Yuri Takahashi, Tsuneji Nagai, Hiraku Onishi, Hiroyuki Suzuki and Hiroshi Masuda and has published in prestigious journals such as Advanced Materials, Langmuir and International Journal of Pharmaceutics.

In The Last Decade

Masanori Iwata

41 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masanori Iwata Japan 11 133 132 75 67 41 45 467
Arindam Halder India 13 117 0.9× 168 1.3× 91 1.2× 40 0.6× 9 0.2× 67 571
Hugo Gonçalves Portugal 14 105 0.8× 27 0.2× 75 1.0× 96 1.4× 8 0.2× 32 457
Gary W. Cleary United States 11 453 3.4× 26 0.2× 61 0.8× 50 0.7× 11 0.3× 17 835
Yoshinori Nakano Japan 11 99 0.7× 64 0.5× 23 0.3× 25 0.4× 10 0.2× 25 337
Eric Ofosu Kissi Denmark 11 163 1.2× 31 0.2× 154 2.1× 100 1.5× 15 0.4× 14 440
Nidhi Mahajan United States 10 227 1.7× 15 0.1× 128 1.7× 53 0.8× 14 0.3× 12 431
Carol A. Steiner United States 11 150 1.1× 51 0.4× 59 0.8× 104 1.6× 4 0.1× 15 599
P. Sakellariou United Kingdom 16 203 1.5× 11 0.1× 127 1.7× 111 1.7× 12 0.3× 39 795
Preeti Gupta India 16 24 0.2× 27 0.2× 126 1.7× 102 1.5× 14 0.3× 46 695
H. Chen United States 7 209 1.6× 92 0.7× 45 0.6× 42 0.6× 2 0.0× 11 483

Countries citing papers authored by Masanori Iwata

Since Specialization
Citations

This map shows the geographic impact of Masanori Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Iwata more than expected).

Fields of papers citing papers by Masanori Iwata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanori Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Iwata. The network helps show where Masanori Iwata may publish in the future.

Co-authorship network of co-authors of Masanori Iwata

This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Iwata. A scholar is included among the top collaborators of Masanori Iwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Iwata. Masanori Iwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakajima, Takanori, Masanori Iwata, Hiroshi Saito, et al.. (2012). Physicopharmaceutical Approach for Hospital Preparation of Mianserin Hydrochloride Suppositories. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 38(11). 702–707. 2 indexed citations
2.
3.
Kiguchi, Kazushige, Chieko Ishiwata, Masanori Iwata, et al.. (2008). Establishment and Characterization of Human Malignant Lymphoma Cell Line Derived from Uterine Cervix. Human Cell. 18(1). 53–58. 1 indexed citations
4.
Sugiyama, M, et al.. (2007). Significance of Pharmacist Intervention in Determining Formulas of Injectable Medicines. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(6). 540–546. 1 indexed citations
5.
Iwata, Masanori, et al.. (2005). Study on Inquiries Concerning Injectable Medicines. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(9). 707–713. 4 indexed citations
6.
Iwata, Masanori, et al.. (2004). Model Project under "Group Hospital Internship Program" Long-term Internship Associated with Educational Reform in Pharmacist Training. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 30(2). 103–112. 12 indexed citations
7.
Iwata, Masanori, et al.. (2003). The Development of a New Dispensing System for the Appropriate Use of Injectable Medicine-H2-receptor Antagonist and Proton Pump Inhibitor-.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29(5). 593–598. 1 indexed citations
8.
Suzuki, Hiroyuki, Hiraku Onishi, Yuri Takahashi, Masanori Iwata, & Yoshiharu Machida. (2003). Development of oral acetaminophen chewable tablets with inhibited bitter taste. International Journal of Pharmaceutics. 251(1-2). 123–132. 67 indexed citations
9.
Kiguchi, Kazushige, Isamu Ishiwata, Chieko Ishiwata, et al.. (2002). Establishment and Characterization of a Lymphoepithelial-like Carcinoma Cell Line (HUUCLEC) Derived from the Human Uterine Cervix.. Human Cell. 15(2). 97–102. 1 indexed citations
10.
Iwata, Masanori, et al.. (2001). Effect of Sodium Caprate against Physical Characteristics and Absorption on Sustained Release Progesterone Suppositories.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 27(2). 137–142. 4 indexed citations
11.
Takahashi, Yuri, Masanori Iwata, & Yoshiharu Machida. (2001). Enhancing Effect of Switching Iontophoresis on Transdermal Absorption of Glibenclamide. YAKUGAKU ZASSHI. 121(2). 161–166. 4 indexed citations
12.
Iwata, Masanori, Kozo Takayama, Yuri Takahashi, et al.. (1998). Release of Diclofenac Sodium from Suppositories Consist of Witepsols as a Base.. Japanese Journal of Hospital Pharmacy. 24(4). 357–362. 1 indexed citations
13.
Iwata, Masanori, et al.. (1996). Spraying Characteristics of Nasal Sprays and their Application to Medication Counseling. Aldecin and Aldecin AQ Nasal.. Japanese Journal of Hospital Pharmacy. 22(6). 564–571. 1 indexed citations
14.
Iwata, Masanori, et al.. (1995). Newly Developed Release Test Method for Suppository.. Japanese Journal of Hospital Pharmacy. 21(1). 29–36. 3 indexed citations
15.
Iwata, Masanori, et al.. (1994). Progesterone Suppositories using Mixtures of Witepsol and Ethylene-Vinyl Acetate Copolymer as a Base.. Japanese Journal of Hospital Pharmacy. 20(6). 515–521. 4 indexed citations
16.
Iwata, Masanori, et al.. (1994). Development of Release Test Method for Suppositories Using Beads and Thimble Filter.. Japanese Journal of Hospital Pharmacy. 20(4). 273–278. 1 indexed citations
17.
Tadokoro, Mamoru, et al.. (1991). Myxoid Variant of Epithelioid Leiomyosarcoma of the Uterus. Acta Pathologica Japonica. 41(10). 778–783. 11 indexed citations
18.
Koizumi, Toru, Nobuyuki Tanaka, Masanori Iwata, & Yoshio Takéuchi. (1987). Preparation of chiral phosphonyl compounds using optically active N-[ethoxyl(phenylthiomethyl)phosphinyl]-L-proline ethyl ester.. NIPPON KAGAKU KAISHI. 1199–1206. 1 indexed citations
19.
Koizumi, Toru, et al.. (1983). Chiral phenylsulfenylmethanephosphonic esters, their preparations and absolute configurations.. Chemical and Pharmaceutical Bulletin. 31(11). 4195–4197.
20.
Machida, Yoshiharu, et al.. (1979). Preparation and phase II clinical examination of topical dosage form for treatment of carcinoma colli containing bleomycin with hydroxypropyl cellulose.. Chemical and Pharmaceutical Bulletin. 27(1). 93–100. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arindam Halder Breakdown of academic impact, for papers by Hugo Gonçalves Breakdown of academic impact, for papers by Gary W. Cleary Breakdown of academic impact, for papers by Yoshinori Nakano Breakdown of academic impact, for papers by Eric Ofosu Kissi Breakdown of academic impact, for papers by Nidhi Mahajan Breakdown of academic impact, for papers by Carol A. Steiner Breakdown of academic impact, for papers by P. Sakellariou Breakdown of academic impact, for papers by Preeti Gupta Breakdown of academic impact, for papers by H. Chen
Rankless by CCL
2026